Home >> Marketplace Archives >> Qiagen partners with Health Innovation Manchester

Qiagen partners with Health Innovation Manchester

Print Friendly, PDF & Email

September 2018—Qiagen announced a partnership with multiple organizations to support creating a worldwide genomics campus in Manchester, U.K., for innovation, life sciences, translational science, and molecular diagnostics. Qiagen is working with Health Innovation Manchester to bring together public, academic, and clinical resources to develop the Genomic Health Innovation Campus, anchored by Qiagen’s European Centre of Excellence for Precision Medicine and hub for diagnostics development. The campus will be built on the Manchester University NHS Foundation Trust’s clinical site in the Corridor Manchester innovation district.

Qiagen, 800-426-8157


Check Also

Qiagen joins forces with SRL to launch companion dx

October 2018—Qiagen announced a collaboration with SRL, a large clinical testing laboratory company in Japan, to prepare for introducing new companion diagnostics simultaneously with new drug approvals. The nonexclusive master collaboration agreement for clinical laboratory research services will enable rapid implementation by SRL of Qiagen’s companion diagnostic workflows upon approval of the drugs and tests by Japan’s Pharmaceuticals and Medical Devices Agency.